4b72: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{STRUCTURE_4b72| PDB=4b72 | SCENE= }} | |||
===Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain=== | |||
{{ABSTRACT_PUBMED_23126626}} | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/BACE1_HUMAN BACE1_HUMAN]] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.<ref>PMID:10677483</ref> <ref>PMID:20354142</ref> | |||
==About this Structure== | |||
[[4b72]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4B72 OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:023126626</ref><references group="xtra"/><references/> | |||
[[Category: Homo sapiens]] | |||
[[Category: Memapsin 2]] | |||
[[Category: Berg, S.]] | |||
[[Category: Blid, J.]] | |||
[[Category: Eketjall, S.]] | |||
[[Category: Falting, J.]] | |||
[[Category: Ginman, T.]] | |||
[[Category: Gravenfors, Y.]] | |||
[[Category: Janson, J.]] | |||
[[Category: Jeppsson, F.]] | |||
[[Category: Johansson, P.]] | |||
[[Category: Karlstrom, S.]] | |||
[[Category: Kieseritzky, F.]] | |||
[[Category: Kihlstrom, J.]] | |||
[[Category: Kolmodin, K.]] | |||
[[Category: Lindstrom, J.]] | |||
[[Category: Olsson, L.]] | |||
[[Category: Rahm, F.]] | |||
[[Category: Slivo, C.]] | |||
[[Category: Stromberg, K.]] | |||
[[Category: Swahn, B.]] | |||
[[Category: Viklund, J.]] | |||
[[Category: Hydrolase]] | |||
[[Category: Hydrolase inhibitor]] | |||
[[Category: Lead generation]] | |||
[[Category: Structure-based drug design]] |
Revision as of 12:52, 30 June 2013
Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in BrainAminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain
Template:ABSTRACT PUBMED 23126626
FunctionFunction
[BACE1_HUMAN] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.[1] [2]
About this StructureAbout this Structure
4b72 is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Ginman T, Viklund J, Malmstrom J, Blid J, Emond R, Forsblom R, Johansson A, Kers A, Lake F, Sehgelmeble F, Sterky KJ, Bergh M, Lindgren A, Johansson P, Jeppsson F, Falting J, Gravenfors Y, Rahm F. Core Refinement toward Permeable beta-Secretase (BACE-1) Inhibitors with Low hERG Activity. J Med Chem. 2013 Jun 13;56(11):4181-205. doi: 10.1021/jm3011349. Epub 2013 May, 20. PMID:23126626 doi:10.1021/jm3011349
- ↑ Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1456-60. PMID:10677483
- ↑ Okada H, Zhang W, Peterhoff C, Hwang JC, Nixon RA, Ryu SH, Kim TW. Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J. 2010 Aug;24(8):2783-94. doi: 10.1096/fj.09-146357. Epub 2010 Mar 30. PMID:20354142 doi:10.1096/fj.09-146357
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Homo sapiens
- Memapsin 2
- Berg, S.
- Blid, J.
- Eketjall, S.
- Falting, J.
- Ginman, T.
- Gravenfors, Y.
- Janson, J.
- Jeppsson, F.
- Johansson, P.
- Karlstrom, S.
- Kieseritzky, F.
- Kihlstrom, J.
- Kolmodin, K.
- Lindstrom, J.
- Olsson, L.
- Rahm, F.
- Slivo, C.
- Stromberg, K.
- Swahn, B.
- Viklund, J.
- Hydrolase
- Hydrolase inhibitor
- Lead generation
- Structure-based drug design